JP Morgan: Will US tax reforms drive pharma M&A in 2018?
The overhaul of the tax system will allow US pharma firms to access billions in capital, but J&J and Merck & Co. play down any changes in their M&A strategy.
Archives for January 9, 2018
Chinese people's concerns about quality of locally made drugs are creating an opportunity for US firms says Gov
Chinese patients’ concerns about the quality of locally made drugs are an opportunity for US manufacturers to increase market share according to the US-China Economic and Security Review Commission.
DNAnexus secures $58m to expand platform in clinical trials market
DNAnexus has secured $58m financing, including a strategic investment from Microsoft, in order to further develop its translational medicine solutions.
Avoca releases vendor prequalification platform
The Avoca Group has launched a new platform to help accelerate the prequalification of clinical service providers and reduce risk in the process.
Orchid says US FDA has closed PADE inspection
Orchid Pharma Ltd has received an Establishment Inspection Report (EIR) from the US FDA for its Chennai facility.
New proposal could delay implementation of the Common Rule
A proposed Final Rule, which would delay the implementation of the revised Common Rule, comes as a surprise to many in the institutional review board (IRB) community, says WCG compliance VP.
China still biggest source of drug ingredients says Indian Health Minister
Indian reliance on China-made drug ingredients continued last year despite Government efforts to encourage drug makers to source from local producers.